Acutus Medical, Inc., a San Diego, CA-based medical device company developing a minimally invasive cardiac catheter for the treatment of irregular heart rhythms, completed a $28m Series B funding.
The round was led by new investor OrbiMed Advisors, LLC along with GE Ventures with participation from existing investors Index Ventures and Advent Life Sciences.
The company intends to use the funds to support product development, clinical trials, regulatory approvals and early commercialization.
Established in 2011 and led by Randy Werneth, CEO, Acutus Medical Since June, 2011, Acutus Medical has developed a real-time 3D Cardiac Chamber Imaging and Dipole Density Mapping system intended to identify the origin of irregular heartbeats, allowing doctors to treat atrial fibrillation (AF) with accuracy.
The company currently has a team of 25 employees.
FinSMEs
20/08/2013
Related News
08/08/2011: Acutus Medical Raises $1M in Initial Funding